Revisiting the use of granulocyte transfusions in pediatric oncology patients

Alan S Graham1, Thomas H Price, Thomas V Brogan

  • 1Department of Pediatrics, Division of Pediatric Critical Care, Oregon Health and Science University, Portland, OR 97239-2901, USA. grahamal@ohsu.edu

Insights

Granulocyte transfusions (GTF) in pediatric oncology patients with neutropenia showed good short-term survival, with 71% surviving hospitalization. However, long-term outcomes remain challenging for this vulnerable population.

Area of Science:

  • Pediatric Hematology-Oncology
  • Transfusion Medicine
  • Infectious Diseases

Background:

  • Neutropenia in pediatric oncology patients significantly increases infection risk.
  • Serious infections in neutropenic patients often require aggressive management.
  • Granulocyte transfusions (GTF) are a supportive therapy option for severe neutropenic infections.

Purpose of the Study:

  • To evaluate the clinical course and outcomes of pediatric oncology patients receiving granulocyte transfusions.
  • To assess the safety and efficacy of GTF in this high-risk population.

Main Methods:

  • Retrospective chart review of 13 pediatric oncology patients (9 months to 16 years) receiving GTF for neutropenic infections between March 1998 and June 2000.
  • Analysis of 14 GTF courses, noting number of transfusions, pre-transfusion infections, and patient outcomes.
  • Evaluation of short-term outcomes including survival to discharge and extubation status.

Main Results:

  • 71% (10/14) of GTF courses were followed by survival to hospital discharge.
  • All 5 intubated patients were extubated after GTF.
  • Despite short-term improvements, the overall mortality rate was 62% (8/13 patients), with two early deaths from invasive Aspergillus.

Conclusions:

  • Granulocyte transfusions were generally well-tolerated in this cohort of septic neutropenic pediatric oncology patients.
  • GTF demonstrated promising short-term survival benefits, including improved respiratory status.
  • Long-term survival remains a significant challenge, highlighting the critical nature of these infections.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...